WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
United Therapeutics revenue was $2.88B for the trailing 12 months ending Dec 31, 2024, with 25.7% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $735.9M, down 1.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, UTHR annual revenue was $2.9B, with 23.6% growth year-over-year.

UTHR past revenue growth

How has UTHR's revenue growth performed historically?

Company
23.63%
Industry
497.69%
Market
20.68%
UTHR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
UTHR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
UTHR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

UTHR revenue history

Current Revenue
$2.9B
Current Earnings
$1.2B
Current Profit Margin
41.5%
UTHR's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when UTHR announces revenue.

UTHR Revenue History By Year

UTHR Yearly RevenueUTHR RevenueUTHR ChangeUTHR Revenue Growth
2024-12-31$2.88B$549.90M+23.63%
2023-12-31$2.33B$391.20M+20.20%
2022-12-31$1.94B$250.80M+14.88%
2021-12-31$1.69B$202.20M+13.63%
2020-12-31$1.48B$34.50M+2.38%
2019-12-31$1.45B-$179.00M-11.00%
2018-12-31$1.63B-$97.50M-5.65%
2017-12-31$1.73B$126.50M+7.91%
2016-12-31$1.60B$133.00M+9.07%
2015-12-31$1.47B$177.30M+13.76%
2014-12-31$1.29B$171.52M+15.36%
2013-12-31$1.12B$200.91M+21.93%
2012-12-31$916.08M$172.89M+23.26%
2011-12-31$743.18M$150.28M+25.35%
2010-12-31$592.90M$234.02M+65.21%
2009-12-31$358.88M$77.38M+27.49%
2008-12-31$281.50M$70.55M+33.45%
2007-12-31$210.94M$51.31M+32.14%
2006-12-31$159.63M$43.72M+37.71%
2005-12-31$115.92M$42.33M+57.51%
2004-12-31$73.59M$20.25M+37.96%
2003-12-31$53.34M$23.22M+77.09%
2002-12-31$30.12M$24.39M+425.56%
2001-12-31$5.73M$3.68M+179.70%
2000-12-31$2.05M$1.61M+369.42%
1999-12-31$436.50k$382.75k+712.08%
1998-12-31$53.75k-$62.16k-53.63%
1997-12-31$115.91kN/AN/A

1 of 2

United Therapeutics Revenue FAQ

What was UTHR's revenue last quarter?

On Invalid Date, United Therapeutics (NASDAQ: UTHR) reported Q4 2024 revenue of $735.90 million up 19.72% year over year. In the same quarter last year, United Therapeutics's revenue was $614.70 million.

What was United Therapeutics's revenue in 2024?

United Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $2.88 billion, a 23.63% increase year over year.

How much does United Therapeutics make in a day?

Based on United Therapeutics annual revenue for the past five years, UTHR makes an average of $5,649,315.07 per day.

What was United Therapeutics's annual revenue growth in the past year?

As of Q2 2025, United Therapeutics's revenue has grown 23.63% year over year. This is 474.07 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. United Therapeutics's revenue in the past year totaled $2.88 billion.

How much does United Therapeutics make in a year?

United Therapeutics's revenue by year for the past five years is:
  • United Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $2.88 billion, a 23.63% increase year over year.
  • United Therapeutics's annual revenue for Dec 31, 2023 was $2.33 billion, a 20.2% increase from 2022.
  • United Therapeutics's annual revenue for 2022 was $1.94 billion, a 14.88% increase from 2021.
  • United Therapeutics's annual revenue for 2021 was $1.69 billion, a 13.63% increase from 2020.
  • United Therapeutics's annual revenue for 2020 was $1.48 billion, a 2.38% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.